Epidermal growth factor receptor (EGFR) mutations occur in 40%–60% of Southeast Asian patients and 10%–20% of Caucasian patients with lung adenocarcinomas and reach occurrences of 50%–60% in non-smoking patients with lung cancer. The gene discussed is EGFR; the disease is lung carcinoma.